Baricitinib is used in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19
Baricitinib is an oral medication that was earlier registered in India for the treatment of moderate to severe active rheumatoid arthritis in adult patients.
Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in-their respective categories as on March 2021.
The company has posted net profit of Rs.11.35 crores for the 12 months period ended March 31, 2021
Oriental Aromatics has reported total income of Rs.710.48 crores for the year ended March 31, 2021
Select global business units to run entirely on renewable energy as of January 2021
The fluorination and photochlorination chemistries will pave the way to tap agrochemical and pharmaceutical customers for DNL
The acquisition essentially involves the takeover of technologies and customer relationships
The company has posted net profit of Rs.73.22 crores for the period ended March 31, 2021
The company has posted net profit of Rs.56.59 crores for the period ended March 31, 2021
TANFAC Industries has reported total income of Rs.149.26 crores for the year ended March 31, 2021
Specialty Chemicals business performed exceedingly well given strong demand from the overseas markets
Deepak Nitrite Ltd reported 38.62% YoY growth in consolidated sales revenues for Q4FY21
Pharmaceutical sales were up by 32% to Rs. 298 crores as compared to Q4 FY20 whereas Crop Protection sales was up by 54% at Rs. 235 crores as compared to Q4 FY20
Entire term loan of Rs. 35 crores was availed by its group company Insunt Trading Private Limited from the Aditya Birla Finance Ltd.
Net income rose on a consolidated basis to Rs 2,221.42 crore during the fourth quarter of 2020-21
This EoI conveys our intention to submit an all-cash voluntary tender offer for its entire share capital at a price of EUR 17.30 per share
This Emergency Use Authorisation will now enable Roche to import the globally manufactured product batches to India
This year marks the start of a new era of growth for Arkema
The consolidated order backlog as on March 31, 2021 stood at Rs. 1,748 crore which comprised 85% domestic orders and 15% international orders
Subscribe to our newsletter & stay updated.
